A bis(mu-carboxylato)(mu-1,8-naphthyridine)diiron(II) complex, [Fe2(BPMAN)(mu-O2CPhCy)2](OTf)2 (1), was prepared by using the 1,8-naphthyridine-based dinucleating ligand BPMAN, where BPMAN = 2,7-bis[bis(2-pyridylmethyl)aminomethyl]-1,8-naphthyridine. The cyclic voltammogram (CV) of this complex in CH2Cl2 exhibited two reversible one-electron redox waves at +296 mV (DeltaE(p) = 80 mV) and +781 mV (DeltaE(p) = 74 mV) vs Cp2Fe+/Cp2Fe, corresponding to the FeIIIFeII/FeIIFeII and FeIIIFeIII/FeIIIFeII couples, respectively. This result is unprecedented for diiron complexes having no single atom bridge. Dinuclear complexes [Fe2(BPMAN)(mu-OH)(mu-O2CPhCy)](OTf)2 (2) and [Mn2(BPMAN)(mu-O2CPhCy)2](OTf)2 (3) were also synthesized and structurally characterized. The cyclic voltammogram of 2 in CH2Cl2 exhibited one reversible redox wave at -22 mV only when the potential was kept below +400 mV. The CV of 3 showed irreversible oxidation at potentials above +900 mV. Diiron(II) complexes [Fe2(BEAN)(mu-O2CPhCy)3](OTf) (4) and [Fe2(BBBAN)(mu-OAc)2(OTf)](OTf) (6) were also prepared and characterized, where BEAN = 2,7-bis(N,N-diethylaminomethyl)-1,8-naphthyridine and BBBAN = 2,7-bis[2-[2-(1-methyl)benzimidazolylethyl]-N-benzylaminomethyl]-1,8-naphthyridine. The cyclic voltammograms of these complexes were recorded. The Mössbauer properties of the diiron compounds were studied.
No takes yet. Share an insight, caveat, or question.
He et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: